lavandula angustifolia extract est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
Pregnancy-safe products containing lavandula angustifolia extract









Related ingredients
Frequently asked questions
- lavandula angustifolia extract est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
- lavandula angustifolia extract est-il sûr pendant l'allaitement ?
- No evidence in regulatory dossiers, SCCS/CIR opinions, or peer‑reviewed literature that Lavandula angustifolia extract causes reproductive or lactation-specific toxicity or transfers in amounts of concern via topical application. Major safety databases (ECHA, EWG Skin Deep) list allergy/irritancy as the primary concerns rather than lactation or developmental toxicity.
- lavandula angustifolia extract est-il sûr pour la peau de bébé ?
- Hazard/mechanism evidence for reproductive or developmental toxicity is absent, so h/m remain 0. Exposure (e) is increased by +1 for infants because infant skin has higher permeability and the ingredient is topically applied; although the extract itself is not reported as highly systemically bioavailable, neonatal skin immaturity makes measurable absorption more likely than in adults. Primary concerns remain topical irritation/allergy rather than developmental toxicity.
- Comment VeriMom évalue-t-il lavandula angustifolia extract ?
- VeriMom évalue lavandula angustifolia extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à lavandula angustifolia extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à lavandula angustifolia extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.